Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation.

Vascular Health and Risk Management
Anselm GittHeinz Völler

Abstract

Metabolic syndrome (MetS) is a clustering of factors that are associated with increased cardiovascular risk. We aimed to investigate the proportion of patients with MetS in patients undergoing cardiac rehabilitation (CR), and to describe differences between patients with MetS compared to those without MetS with regard to (1) patient characteristics including demographics, risk factors, and comorbidities, (2) risk factor management including drug treatment, and (3) control status of risk factors at entry to CR and discharge from CR. Post-hoc analysis of data from 27,904 inpatients (Transparency Registry to Objectify Guideline-Oriented Risk Factor Management registry) that underwent a CR period of about 3 weeks were analyzed descriptively in total and compared by their MetS status. In the total cohort, mean age was 64.3 years, (71.7% male), with no major differences between groups. Patients had been referred after a ST elevation of myocardial infarction event in 41.1% of cases, non-ST elevation of myocardial infarction in 21.8%, or angina pectoris in 16.7%. They had received a percutaneous coronary intervention in 55.1% and bypass surgery (coronary artery bypass graft) in 39.5%. Patients with MetS (n = 15,819) compared to those w...Continue Reading

Associated Clinical Trials

References

Sep 22, 2001·The New England Journal of Medicine·P A Ades
Aug 20, 2003·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Daniel EinhornPeter W F Wilson
Mar 26, 2004·European Journal of Clinical Pharmacology·D PittrowH-U Wittchen
Apr 13, 2004·Journal of Hypertension·Arya M SharmaUNKNOWN HYDRA Study Group
Feb 2, 2006·Annals of Medicine·Dianna J MaglianoPaul Z Zimmet
Mar 21, 2006·Atherosclerosis·S BöhlerUNKNOWN DETECT-Study Group
Aug 10, 2006·Medizinische Klinik·David PittrowHans-Ulrich Wittchen
Feb 16, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Marthin KaroffBirna Bjarnason-Wehrens
Jun 6, 2008·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Kurt BestehornHeinz Völler
Sep 13, 2008·Journal of the American College of Cardiology·Mohan C MadalaUNKNOWN CRUSADE Investigators
Apr 17, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Anselm K GittKurt Bestehorn
Jun 4, 2010·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Anselm K GittKurt Bestehorn
Nov 26, 2010·Circulation·Philip GreenlandUNKNOWN American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Apr 2, 2011·Expert Review of Cardiovascular Therapy·Nkechinyere Ijioma, Jennifer G Robinson

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

SAS

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved